Diabetes and Ayurved
Completed
- Conditions
- PRAMEHI
- Registration Number
- CTRI/2018/04/013525
- Lead Sponsor
- GOVERMENT AKANDANAND AYURVED COLLEGE AHMEDABAD
- Brief Summary
This study is rendomised, participiant,blinded,parellel group,active controlled trial to compare the efficasy of chitarakadikwath 40 ml bd with or without vaman karma with the dutation of 6weeks after vaman karma in 30 patienis of sthool prameha.Which will be conducted in india.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patient having classical signs and symptoms of the disease according to Ayurveda well as Modern science. 1 Patients of Prameha having BMI 25 to 35 2 Patient of NIDDM with blood sugar level more then.
- F.B.S.- 126 mg/dl or P.P.B.S.-180 mg/dl. 3 Age group of 16-60 years. 4 Disease chronicity 10 year. 5 Patient otherwise healthy and fit for Shodhana(Vamana) and Chirakadikwath as per the Ayurvedic text.
Exclusion Criteria
- Patients of Prameha having BMI < 25 &>35 1 Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin.
- 2 Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot,Carbuncles etc.
- 3 Age <16 to > 60 years.
- 4 Patients having Diabetes in association with other endocrinopathies like Pheochromocytoma, Acromegaly, Cushing’s syndrome, Hyperthyroidism etc.
- 5 Patients having drug or chemical induced Type-II Diabetes, like glucocorticoids induced or thyroid hormone induced etc.
- 6 Patients with genetic syndromes associated with Type-II Diabetes like Down’s syndrome, Klinefelter’s Syndrome, and Turner’s syndrome etc.
- 7 Patients complicated with any cardiovascular diseases, renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All the signs and symptoms of Pramehi will be assigned score depending upone their severity to assess the effect of the drugsat the time of before treatment and after treatment. After 3 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Vamana Karma in managing Sthool Prameha (Type 2 Diabetes Mellitus)?
How does Chitrakadi Kwath compare to standard-of-care therapies for Type 2 Diabetes in terms of glycemic control and metabolic outcomes?
Are there specific biomarkers that correlate with response to Vamana Karma or Chitrakadi Kwath in Ayurvedic diabetes management?
What are the potential adverse events associated with Vamana Karma and how are they managed in clinical practice?
What combination approaches in Ayurvedic treatment for Type 2 Diabetes show synergistic effects with Vamana Karma or Chitrakadi Kwath?
Trial Locations
- Locations (1)
GOVT AKHANDANAND AYURVED COLLEGE AND HOSPITAL AHMEDABAD AND MANIBEN AYURVED HOSPITAL AHMEDABAD
🇮🇳Ahmadabad, GUJARAT, India
GOVT AKHANDANAND AYURVED COLLEGE AND HOSPITAL AHMEDABAD AND MANIBEN AYURVED HOSPITAL AHMEDABAD🇮🇳Ahmadabad, GUJARAT, IndiaNIHARIKA JITENDRAKUMAR PRAJAPATIPrincipal investigator7778994755drniharikaprajapati15@gmail.com